可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1] Fujii H, Kim JI, Abe T, et al. Relationship between parathyroid hormone and cardiac abnormalities in chronic dialysis patients[J]. Intern Med, 2007, 46(18):1507-1512.
[2] Mitsnefes MM, Kimball TR, Kartal J, et al. Progression of left ventricular hypertrophy in children with early chronic kidney disease: 2-year follow-up study[J]. J Pediatr, 2006, 149(5):671-675.
[3] Yang L, Zou X, Liang Q, et al. Sodium tanshinone IIA sulfonate depresses angiotensin II-induced cardiomyocyte hypertrophy through MEK/ERK pathway[J]. Exp Mol Med, 2007, 39(1):65-73.
[4] 朱肖星,梅其炳,刘莉,等. 内皮素-1对新生大鼠心肌细胞的影响及机制[J]. 心脏杂志, 2005, 17(5):441-444.
[5] De Jonge HW, Dekkers DH, Houtsmuller AB, et al. Differential signaling and hypertrophic responses in cyclically stretched vs endothelin-1 stimulated neonatal rat cardiomyocytes[J]. Cell Biochem Biophys, 2007, 47(1):21-32.
[6] Joy MS, Karagiannis PC, Peyerl FW. Outcomes of secondary hyperparathyroidism in chronic kidney disease and the direct costs of treatment[J]. J Manag Care Pharm, 2007, 13(5):397-411.
[7] Tomilina NA, Storozhakov GI, Gendlin GE, et al. Risk factors and pathogenetic mechanisms of left ventricular hypertrophy in progressive chronic kidney disease and after transplantation of the kidney[J]. Ter Arkh, 2007, 79(6):34-40.
[8] Krauser DG, Devereux RB. Ventricular hypertrophy and hypertension: prognostic elements and implications for management[J]. Herz, 2006, 31(4):305-316.
[9] 杨丽霞,王先梅,石燕昆,等. 细胞外信号调节激酶的变化在心力衰竭患者心肌重构中的意义[J]. 心脏杂志, 2006, 18(1):62-64.